Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Apellis Pharmaceuticals (APLS) Q4 2023 Earnings
APLS
27
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.56
-1.28
-1.01
-0.73
Details
Expected EPS
-0.730739
Actual EPS
-0.73
Surprise EPS
0
Surprise Percent
+0.1%
Description
Apellis Pharmaceuticals (APLS) has reported earnings of -0.73 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login